Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation and Management of Antenatal Hydronephrosis

  • Hong, Young Kwon (Department of Urology, CHA Bundang Medical Center, CHA University) ;
  • Lee, Jun Ho (Department of Pediatrics, CHA Bundang Medical Center, CHA University)
  • Received : 2015.02.28
  • Accepted : 2015.04.25
  • Published : 2015.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Antenatal hydronephrosis (ANH) is one of the most common abnormal findings detected on prenatal ultrasound (US), and it has been reported in 1-5% of all pregnancies. The likelihood of significant postnatal pathologic abnormality in the urinary tract correlates with the degree of anterior-posterior diameter (APD) according to the gestational age. Detection of urologic anomalies prenatally permits fetal interventions that avoid complications in rare cases of bladder outlet obstruction with oligohydramnios even though their final benefits still remain controversial. There is no clear consensus on the extent and mode of postnatal imaging after a diagnosis of ANH. US is the mainstay of the postnatal evaluation and helps guide further testing with voiding cystourethrography (VCUG) and diuretic renography. Although most algorithms continue to recommend generous VCUG for identification of lower urinary tract anomalies, VCUG may be safely reserved for high grade ANH cases or any grade of ANH with dilated distal ureter without increasing the risk of urinary tract infection (UTI). There are conflicting studies about efficacy of postnatal prophylactic antibiotics. It still seems reasonable to consider use of a prophylactic antibiotic to prevent infant UTIs in high-risk populations, such as females and uncircumcised males with high grades of hydronephrosis, hydroureteronephrosis, or vesicouretral reflux.

Keywords

References

  1. Kitchens DM, Herndon CD. Antenatal hydronephrosis. Curr Urol Rep 2009;10:126-33. https://doi.org/10.1007/s11934-009-0023-x
  2. Pates JA, Dashe JS. Prenatal diagnosis and management of hydronephrosis. Early Hum Dev 2006;82:3-8. https://doi.org/10.1016/j.earlhumdev.2005.11.003
  3. Herndon CD. Antenatal hydronephrosis: differential diagnosis, evaluation, and treatment options. Scientific World Journal 2006;6:2345-65. https://doi.org/10.1100/tsw.2006.366
  4. Anderson N, Clautice-Engle T, Allan R, Abbott G, Wells JE. Detection of obstructive uropathy in the fetus: predictive value of sonographic measurements of renal pelvic diameter at various gestational ages. AJR Am J Roentgenol 1995;164:719-23. https://doi.org/10.2214/ajr.164.3.7863901
  5. Bobrowski RA, Levin RB, Lauria MR, Treadwell MC, Gonik B, Bottoms SF. In utero progression of isolated renal pelvis dilation. Am J Perinatol 1997;14:423-6. https://doi.org/10.1055/s-2007-994173
  6. Odibo AO, Raab E, Elovitz M, Merrill JD, Macones GA. Prenatal mild pyelectasis: evaluating the thresholds of renal pelvic diameter associated with normal postnatal renal function. J Ultrasound Med 2004;23:513-7. https://doi.org/10.7863/jum.2004.23.4.513
  7. Babcook CJ, Silvera M, Drake C, Levine D. Effect of maternal hydration on mild fetal pyelectasis. J Ultrasound Med 1998;17:539-44. https://doi.org/10.7863/jum.1998.17.9.539
  8. Robinson JN, Tice K, Kolm P, Abuhamad AZ. Effect of maternal hydration on fetal renal pyelectasis. Obstet Gynecol 1998;92:137-41. https://doi.org/10.1016/S0029-7844(98)00136-7
  9. Leung VY, Chu WC, Metreweli C. Hydronephrosis index: a better physiological reference in antenatal ultrasound for assessment of fetal hydronephrosis. J Pediatr 2009;154:116-20. https://doi.org/10.1016/j.jpeds.2008.06.032
  10. Nguyen HT, Herndon CD, Cooper C, Gatti J, Kirsch A, Kokorowski P, et al. Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol 2010;6:212-31. https://doi.org/10.1016/j.jpurol.2010.02.205
  11. Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. Pediatr Radiol 1993;23:478-80. https://doi.org/10.1007/BF02012459
  12. Chavhan G, Daneman A, Moineddin R, Lim R, Langlois V, Traubici J. Renal pyramid echogenicity in ureteropelvic junction obstruction: correlation between altered echogenicity and differential renal function. Pediatr Radiol 2008;38:1068-73. https://doi.org/10.1007/s00247-008-0943-5
  13. Chi T, Feldstein VA, Nguyen HT. Increased echogenicity as a predictor of poor renal function in children with grade 3 to 4 hydronephrosis. J Urol 2006;175:1898-901. https://doi.org/10.1016/S0022-5347(05)00930-4
  14. Daikha-Dahmane F, Dommergues M, Muller F, Narcy F, Lacoste M, Beziau A, et al. Development of human fetal kidney in obstructive uropathy: correlations with ultrasonography and urine biochemistry. Kidney Int 1997;52:21-32. https://doi.org/10.1038/ki.1997.299
  15. Oliveira EA, Diniz JS, Cabral AC, Leite HV, Colosimo EA, Oliveira RB, et al. Prognostic factors in fetal hydronephrosis: a multivariate analysis. Pediatr Nephrol 1999;13:859-64. https://doi.org/10.1007/s004670050716
  16. Oliveira EA, Diniz JS, Cabral AC, Pereira AK, Leite HV, Colosimo EA, et al. Predictive factors of fetal urethral obstruction: a multivariate analysis. Fetal Diagn Ther 2000;15:180-6. https://doi.org/10.1159/000021002
  17. Oliveira EA, Rabelo EAS, Pereira AK, Diniz JS, Cabral ACV, Leite HV, et al. Prognostic factors in prenatally-detected posterior urethral valves: a multivariate analysis. Pediatr Surg Int 2002;18:662-7. https://doi.org/10.1007/s00383-002-0877-1
  18. Clark TJ, Martin WL, Divakaran TG, Whittle MJ, Kilby MD, Khan KS. Prenatal bladder drainage in the management of fetal lower urinary tract obstruction: a systematic review and meta-analysis. Obstet Gynecol 2003;102:367-82.
  19. Morris RK, Malin GL, Quinlan-Jones E, Middleton LJ, Hemming K, Burke D, et al. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Lancet 2013;382:1496-506. https://doi.org/10.1016/S0140-6736(13)60992-7
  20. Spiro JE, Konrad M, Rieger-Fackeldey E, Masjosthusmann K, Amler S, Klockenbusch W, Schmitz R. Renal oligo- and anhydramnios: cause, course and outcome-a single-center study. Arch Gynecol Obstet. 2015 Feb 13. [Epub ahead of print]
  21. Bassanese G, Travan L, D'Ottavio G, Monasta L, Ventura A, Pennesi M. Prenatal anteroposterior pelvic diameter cutoffs for postnatal referral for isolated pyelectasis and hydronephrosis: more is not always better. J Urol. 2013;190:1858-63. https://doi.org/10.1016/j.juro.2013.05.038
  22. Bomalaski MD, Hirschl RB, Bloom DA. Vesicoureteral reflux and ureteropelvic junction obstruction: association, treatment options and outcome. J Urol 1997;157:969-74. https://doi.org/10.1016/S0022-5347(01)65121-8
  23. Lee RS, Cendron M, Kinnamon DD, Nguyen HT. Antenatal hydronephrosis as a predictor of postnatal outcome: a meta-analysis. Pediatrics 2006;118:586-93. https://doi.org/10.1542/peds.2006-0120
  24. St Aubin M, Willihnganz-Lawson K, Varda BK, Fine M, Adejoro O, Prosen T, et al. Society for fetal urology recommendations for postnatal evaluation of prenatal hydronephrosis-- will fewer voidingcystourethrograms lead to more urinary tract infections? J Urol 2013;190(4 Suppl):1456-61. https://doi.org/10.1016/j.juro.2013.03.038
  25. Vasconcelos MA, Bouzada MC, Silveira KD, Moura LR, Santos FF, Oliveira JM, et al. Urinary levels of TGF ${\beta}$-1 and of cytokines in patients with prenatally detected nephrouropathies. Pediatr Nephrol 2011;26(5):739-47. https://doi.org/10.1007/s00467-011-1802-4
  26. Madsen MG, Norregaard R, Frokiaer J, Jorgensen TM. Urinary biomarkers in prenatally diagnosed unilateral hydronephrosis. J Pediatr Urol 2011;7:105-12. https://doi.org/10.1016/j.jpurol.2010.12.004
  27. Furness III PD, Maizels M, Han SW, Cohn RA, Cheng EY. Elevated bladder urine concentration of transforming growth factorbeta1 correlates with upper urinary tract obstruction in children. J Urol 1999;162(3 pt 2):1033-6. https://doi.org/10.1016/S0022-5347(01)68056-X
  28. Madsen MG, Norregaard R, Palmfeldt J, Olsen LH, Frokiaer J, Jorgensen TM. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis. J Pediatr Urol 2013;9(6 pt A):838-45. https://doi.org/10.1016/j.jpurol.2012.11.011
  29. Taranta-Janusz K, Wasilewska A, Debek W, Waszkeiwicz-Stojda M. Urinary cytokine profiles in unilateral congenital hydronephrosis. Pediatr Nephrol 2012;27:2107-13. https://doi.org/10.1007/s00467-012-2230-9
  30. Madsen MG, Norregaard R, Palmfeldt J, Olsen LH, Frokiaer J, Jorgensen TM. Urinary NGAL, cystatin C, ${\beta}2$-microglobulin, and osteopontin significance in hydronephrotic children. Pediatr Nephrol 2012;27:2099-106. https://doi.org/10.1007/s00467-012-2217-6
  31. Cost NG, Noh PH, Devarajan P, Ivancic V, Reddy PP, Minevich E, et al. Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty. J Urol 2013;190(4 Suppl):1462-7. https://doi.org/10.1016/j.juro.2013.05.003
  32. Walsh TJ, Hsieh S, Grady R, Mueller BA. Antenatal hydronephrosis and the risk of pyelonephritis hospitalization during the first year of life. Urology 2007;69:970-4. https://doi.org/10.1016/j.urology.2007.01.062
  33. Coelho GM, Bouzada MC, Pereira AK, Figueiredo BF, Leite MR, Oliveira DS, et al. Outcome of isolated antenatal hydronephrosis: a prospective cohort study. Pediatr Nephrol 2007;22:1727-34. https://doi.org/10.1007/s00467-007-0539-6
  34. Lee JH, Choi HS, Kim JK, Won H-S, Kim KS, Moon DH, et al. Nonrefluxing neonatal hydronephrosis and the risk of urinary tract infection. J Urol 2008;179:1524-8. https://doi.org/10.1016/j.juro.2007.11.090
  35. Yavascan O, Aksu N, Anil M, Kara OD, Aydin Y, Kangin M, et al. Postnatal assessment of growth, nutrition, and urinary tract infections of infants with antenatally detected hydronephrosis. Int Urol Nephrol 2010;42:781-8. https://doi.org/10.1007/s11255-009-9530-4
  36. Song SH, Lee SB, Park YS, Kim KS. Is antibiotic prophylaxis necessary in infants with obstructive hydronephrosis? J Urol 2007;177:1098-101. https://doi.org/10.1016/j.juro.2006.11.002
  37. Alconcher L, Tombesi M. Mild antenatal hydronephrosis: management controversies. Pediatr Nephrol 2004;19:819-20. https://doi.org/10.1007/s00467-004-1476-2
  38. Estrada CR, Peters CA, Retik AB, Nguyen HT. Vesicoureteral reflux and urinary tract infection in children with a history of prenatal hydronephrosis--should voiding cystourethrography be performed in cases of postnatally persistent grade II hydronephrosis? J Urol 2008;181:801-6.
  39. Braga LH, Mijovic H, Farrokhyar F, Pemberton J, DeMaria J, Lorenzo AJ. Antibiotic prophylaxis for urinary tract infections in antenatal hydronephrosis. Pediatrics 2013;131:e251-61. https://doi.org/10.1542/peds.2012-1870
  40. Herz D, Merguerian P, McQuiston L. Continuous antibiotic prophylaxis reduces the risk of febrile UTI in children with asymptomatic antenatal hydronephrosis with either ureteral dilation, high-grade vesicoureteral reflux, or ureterovesical junction obstruction. J Pediatr Urol 2014;10:650-4. https://doi.org/10.1016/j.jpurol.2014.06.009
  41. Braga LH, Farrokhyar F, D'Cruz J, Pemberton J, Lorenzo AJ. Risk factors for febrile urinary tract infection in children with prenatal hydronephrosis: a prospective study. J Urol 2015 Mar 23. pii: S0022-5347(14)04772-7. doi: 10.1016/j.juro.2014.10.091. [Epub ahead of print].

Cited by

  1. Postnatal Evaluation and Outcome of Prenatal Hydronephrosis vol.26, pp.2, 2015, https://doi.org/10.5812/ijp.3667